• Article highlight
  • Article tables
  • Article images

Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 805

PDF Downloaded: 869


Get Permission Nikhilesh, Vadhanan, Megha, and Tripaty: A case report of vasopressin induced bradycardia and dyspnea after intramyometrial injection during myomectomy


Introduction

During myomectomy blood loss and intraoperative need for blood transfusion can be significantly reduced by local infiltration of vasopressin.1 But even a low dose of vasopressin is associated with adverse side effects.1 We report a patient who developed sudden bradycardia, dyspnea & non recordable blood pressure immediately after intamyometrial injection of vasopressin.

Case Report

A 33yrs old woman was scheduled for an open myomectomy in view of uterine fibroid. Her baseline blood investigations, chest x-ray & ecg were normal. She had no significant past medical illness and no history of surgeries in the past.

After pre Anesthetic checkup she was fit and assessed under American society of anesthesiologists –II and surgery was planned. Patient was kept nil per oral for 8hrs, pre medicated with tablet rantac 150mg and tablet diazepam 5mg night before and on the morning of surgery. In pre operative holding area her baseline vitals were stable (pulse - 82/min, nibp - 126/84 mm of hg, Spo2 - 100% at room air). ECG showed normal sinus rhythm. IV line was secured with 18g cannula on dorsal aspect of left wrist and she was preloaded with 500ml of ringer lactate.

Patient was shifted to OT and was put in right lateral position. Subarachnoid block was given after identifying l3-l4 intervertebral space 3ml of inj. bupivacaine 0.5% heavy as injected intrathecally using a 23g spinal needle and patient was changed to supine position. After 5 mins of anesthesia her PR was 68/min, nibp - 110/68 mm hg.

After 30 minutes of sub arachnoid block, intraoperatively surgeon after communicating to the anesthetist, injected 5units of vasopressin diluted in 20ml of normal saline intramyometrially after confirming negative aspiration of blood before injecting .Immediately patient was restless and complained of dyspnea and had a sudden drop in heart rate upto 21/min and ECG showed sinus bradycardia,

Surgery was kept on hold and patient was resuscitated by administering three doses of injection atropine 0.6mg i.v (30 secs between each dose) & oxygen (6 l/min) was supplemented through a face mask.

The event lasted for three minutes and patient remained dyspneic and complained of chest discomfort. Gradually heart rate increased upto 90-110/min andnibp was 176/112 mm hg. Patient was then induced with inj. propofol 100mg i.v & a classical LMA size 3 was placed in oral cavity to maintain spontaneous ventilation. She was maintained with isoflurane 1% in oxygen/nitrous oxide mixture. Within next 10 minutes the patient became haemodynamically stable, surgery was resumed and completed with no further complications.

Follow up and outcomes

Her post-operative period was uneventful and she was discharged on post operative day 6.

Discussion

Vasopressin is principally an anti-diuretic hormone which acts on v1 receptors and produces generalized constriction of blood vessels including coronary vasculature when given at higher doses. It effectively reduces blood loss in uterine myomectomy. The effects include reduced cardiac output and heart rate resulting from vasoconstriction.2

In the above case report patient exhibited bradycardia after infiltrating with vasopressin intramyometrially. Pinprick test performed after spinal anesthesia ruled out chances of high spinal anesthesia. However the patient had no bradycardia, dyspnea prior to vasopressin administration. So the diagnosis was in favor of adverse effects with vasopressin rather than high spinal anaesthesia.3, 4

Excessive bleeding in uterine myomectomy is a life-threatening complication. Few case reports suggest that to minimize blood loss vasopressin is commonly used as a haemostatic agent.5, 6, 7, 8, 9, 10

Conclusion

Vasopressin administering intramyometrially shown bradycardia, dyspnea as anticipated complications. This scenario may be life threatening if not treated immediately. We recommend the dilution used and the total administered dose should be as small as possible and close monitoring for hemostasis. Considering other medical and surgical technique to reduce uterine bleeding can be adopted. Communication between the anesthesiologist and the surgeon is important to identify and treat this rare complication.

Source of Funding

None.

Conflict of Interest

None.

References

1 

G Chilkoti M Mohta S Nath A K Saxena P Khurana Anaesthetic concerns with intramyometrial vasopressin during myomectomyAin-Shams J Anaesthesiol2016945210.4103/1687-7934.189089

2 

M Muthukumar L Mathews N S Vasantha S Anoop Intramyometrial vasopressin as a haemostatic agent: Is it really safe?Indian J Anaesth20155915110.4103/0019-5049.149456

3 

B P Butala V R Shah B K Parikh J Jayaprakash J Kalo Bradycardia and severe vasospasm caused by intramyometrial injection of vasopressin during myomectomySaudi J Anaesth20148339610.4103/1658-354x.136630

4 

M H Hung Y M Wang Y Y Chia Y M Chou K Liu Intramyometrial injection of vasopressin causes bradycardia and cardiac arrest - report of two casesActa Anaesthesiol Taiwan2006442437

5 

H Byrne T Miskry C M H Gomez Using Vasopressin for MyomectomyObstet Gynecol20091141697010.1097/aog.0b013e3181ac3f43

6 

M L Riess J G Ulrichs P S Pagel H J Woehlck Case report: Severe vasospasm mimics hypotension after high-dose intrauterine vasopressinAnesth Analg2011113511035

7 

G Frishman Vasopressin: if some is good, is more better?Obstet Gynecol20091132476710.1097/AOG.0b013e31819698bb

8 

A Deschamps S Krishnamurthy Absence of pulse and blood pressure following vasopressin injection for myomectomyCan J Anesth2005525552310.1007/bf03016547

9 

M M Saha Khushboo S C Biswas Assessment of Blood Loss in Abdominal Myomectomy by Intramyometrial Vasopressin Administration Versus Conventional Tourniquet ApplicationJ Clin Diagn Res2016105103

10 

E J Kongnyuy C S Wiysonge Interventions to reduce haemorrhage during myomectomy for fibroidsCochrane Database Syst Rev2007110.1002/14651858.CD005355.pub2



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.